Clinical Trial Update: Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]

View source ↗

Summary

Clinical study of YS110 in malignant pleural mesothelioma has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• YS110

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Malignant Pleural Mesothelioma | Phase 1, Phase 2 | Status: COMPLETED